ENCRYPTION AND SECURITY OF BIOLOGICAL DESIGN FILES

Detailed Explanation with Case Laws

1. INTRODUCTION

Encryption and security of biological design files is an emerging field of biotechnology law, cyber law, data protection law, and intellectual property law. Biological design files are digital records containing DNA sequences, RNA sequences, genetic constructs, plasmid designs, protein structures, synthetic biology models, and other scientific information.

These files are used by biotechnology companies, universities, research laboratories, pharmaceutical industries, and synthetic biology organizations. Unauthorized access, theft, modification, or disclosure of such files may result in intellectual property infringement, privacy violations, research misconduct, and biological security risks.

Encryption refers to the process of converting information into a protected form so that only authorized persons possessing the appropriate cryptographic keys can access it. Security of biological design files includes technical, organizational, and legal measures designed to protect confidentiality, integrity, authenticity, and availability.

Therefore, the primary objective of this legal framework is to protect scientific innovation, sensitive biological information, and legitimate research activities against unauthorized access and misuse.

2. MEANING AND SCOPE

Encryption and security of biological design files means protecting digital biological information through appropriate technological safeguards and legal obligations.

Its scope includes:

DNA and RNA sequence databases.

Synthetic biology and genetic engineering design files.

Laboratory research records and experimental data.

Genomic and personal biological information.

Confidential biotechnology inventions and trade secrets.

Cloud-based biological databases.

AI-generated biological design files and associated records.

The applicable legal rules depend on the nature of the information, the jurisdiction, the purpose of processing, and whether the files contain personal data, confidential information, or material subject to special biosecurity requirements.

3. OBJECTIVES OF ENCRYPTION AND SECURITY

The main objectives are:

A. Confidentiality: To prevent unauthorized persons from accessing sensitive biological information.

B. Integrity: To ensure that DNA sequences, research results, and design records are not altered without authorization.

C. Authentication: To verify the identity of users and the origin of biological files.

D. Access Control: To ensure that only authorized researchers and personnel can access particular files.

E. Data Privacy: To protect identifiable genomic and health-related information.

F. Intellectual Property Protection: To prevent unauthorized copying or commercial exploitation of confidential biotechnology inventions.

G. Biosecurity: To reduce the risk that sensitive biological design information will be accessed or misused unlawfully.

H. Research Reliability: To preserve accurate records, file versions, and scientific provenance.

4. LEGAL FRAMEWORK IN INDIA

A. Information Technology Act, 2000

The Information Technology Act, 2000 is relevant to unauthorized access, copying, extraction, and disclosure involving computer systems.

Section 43 provides for liability for specified unauthorized acts involving computer systems and data.

Section 66 addresses specified acts under Section 43 when committed dishonestly or fraudulently.

Section 72 addresses breach of confidentiality and privacy in the circumstances covered by the provision.

Section 72A addresses disclosure of personal information in breach of a lawful contract, subject to statutory requirements.

These provisions may apply where biological design files are unlawfully accessed, copied, altered, or disclosed.

B. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 is relevant where biological records contain digital personal data and the Act applies.

Genomic information may qualify as personal data when it relates to an identifiable individual. However, not every biological design file or DNA sequence automatically constitutes personal data.

The applicable security obligations must be determined by reference to the Act, its rules, and their commencement and transitional provisions.

C. Copyright Act, 1957

The Copyright Act, 1957 may protect qualifying original computer programs, databases, and other copyrightable expression used in biotechnology.

However, copyright does not automatically protect every scientific fact, biological principle, or DNA sequence as such.

D. Patents Act, 1970

The Patents Act, 1970 governs patent protection for qualifying inventions. Biotechnology inventions must satisfy the applicable requirements of patentability and statutory exclusions.

Encryption itself does not establish patent ownership or create patent rights.

E. Contractual and Trade-Secret Protection

Confidential biological designs may be protected through non-disclosure agreements, research collaboration agreements, employment contracts, licensing agreements, and applicable principles governing confidential information.

These arrangements can impose duties concerning access, storage, disclosure, transfer, and permitted use of biological design files.

5. ESSENTIAL SECURITY MEASURES

Biotechnology organizations should implement the following safeguards:

Encryption at Rest: Protect files stored on computers, servers, portable devices, and cloud platforms.

Encryption in Transit: Protect biological files during electronic transmission.

Multifactor Authentication: Require additional identity verification for sensitive repositories.

Role-Based Access Control: Restrict access according to professional responsibilities.

Integrity Verification: Use suitable cryptographic hashes and digital signatures to identify unauthorized changes.

Secure Key Management: Restrict access to encryption keys and establish secure recovery procedures.

Audit Trails: Record access, downloads, modifications, and transfers.

Secure Backups: Maintain protected backups and test recovery procedures.

Vendor Security: Assess cloud providers, contractual obligations, and incident-response arrangements.

Incident Response: Investigate security incidents, preserve evidence, and comply with applicable reporting obligations.

Encryption should be supported by staff training, documented security policies, version control, and regular risk assessments.

6. IMPORTANT CASE LAWS

There is no single leading judgment that specifically establishes a comprehensive encryption requirement for biological design files. The following cases provide relevant legal principles by analogy.

CASE LAW 1: JUSTICE K.S. PUTTASWAMY (RETD.) V. UNION OF INDIA (2017)

Citation: (2017) 10 SCC 1.

Court: Supreme Court of India.

Facts and Principle: The Supreme Court recognized privacy as a fundamental right under the Constitution, particularly under Article 21. The judgment discussed informational privacy and the protection of individuals against unjustified intrusions.

Relevance: Where biological files contain identifiable genomic or health information, privacy principles support appropriate access restrictions and safeguards against unauthorized disclosure.

CASE LAW 2: SHREYA SINGHAL V. UNION OF INDIA (2015)

Citation: (2015) 5 SCC 1.

Court: Supreme Court of India.

Facts and Principle: The Supreme Court struck down Section 66A of the Information Technology Act, 2000 because it violated freedom of speech and expression under Article 19(1)(a). The judgment also considered aspects of intermediary liability.

Relevance: The case demonstrates that cybersecurity regulation and digital restrictions must comply with constitutional principles. Security measures should be legally justified and proportionate.

CASE LAW 3: R. RAJAGOPAL V. STATE OF TAMIL NADU (1994)

Citation: (1994) 6 SCC 632.

Court: Supreme Court of India.

Facts and Principle: The Court examined privacy rights in relation to the publication of information concerning an individual's life and considered the relationship between privacy and freedom of the press.

Relevance: Biological files containing identifiable genetic information may raise important privacy and confidentiality concerns. Their disclosure must be assessed under the applicable legal framework.

CASE LAW 4: DISTRICT REGISTRAR AND COLLECTOR V. CANARA BANK (2005)

Citation: (2005) 1 SCC 496.

Court: Supreme Court of India.

Facts and Principle: The Court considered statutory powers to inspect private documents and emphasized the constitutional importance of privacy and protection against unjustified intrusion into private records.

Relevance: The judgment supports the broader principle that access to confidential records must have an appropriate legal basis. This principle may inform the protection of sensitive biological research records.

CASE LAW 5: VAN BUREN V. UNITED STATES (2021)

Citation: 593 U.S. 374.

Court: Supreme Court of the United States.

Facts and Principle: The case concerned a police officer who accessed a law-enforcement database for an improper purpose. The Court interpreted the relevant provision of the US Computer Fraud and Abuse Act concerning access to information beyond a person's authorized access.

Relevance: The decision illustrates the importance of clearly defined access permissions. Biotechnology laboratories should restrict sensitive files to authorized users and maintain records of access.

CASE LAW 6: CARPENTER V. UNITED STATES (2018)

Citation: 585 U.S. 296.

Court: Supreme Court of the United States.

Facts and Principle: The Court held that government acquisition of historical cell-site location information in the circumstances of the case constituted a Fourth Amendment search generally requiring a warrant supported by probable cause.

Relevance: The decision illustrates the legal importance of sensitive digital information and limits on certain forms of access. Its direct holding concerns location information, not biological files or encryption.

CASE LAW 7: CARPENTER V. UNITED STATES (1987)

Citation: 484 U.S. 19.

Court: Supreme Court of the United States.

Facts and Principle: The case concerned the unauthorized commercial use of confidential advance information from newspaper columns. The Court upheld the application of federal mail and wire fraud laws to the fraudulent scheme.

Relevance: The case illustrates the legal significance of confidential commercial information. Unauthorized disclosure of proprietary biological designs may similarly cause commercial harm, subject to the applicable legal requirements.

7. LEGAL RESPONSIBILITIES OF BIOTECHNOLOGY ORGANIZATIONS

Biotechnology organizations have important responsibilities concerning biological design files.

A. Confidentiality: Organizations should identify sensitive information and establish appropriate confidentiality obligations.

B. Lawful Data Processing: They should determine whether genomic files contain personal data and comply with applicable privacy laws.

C. Access Governance: Access permissions should be based on documented research requirements and professional responsibilities.

D. Secure Collaboration: Organizations should use suitable agreements and protected transfer systems when exchanging files with external laboratories.

E. Incident Reporting: Security incidents should be investigated, and applicable notification requirements should be followed.

F. Evidence Preservation: Organizations should preserve relevant logs, file versions, and access records for investigations.

G. Research Integrity: Security controls should preserve the reliability, reproducibility, and lawful exchange of scientific information.

8. MAJOR LEGAL CHALLENGES

1. Cross-Border Data Transfers: Biological files may be stored in one country and accessed in another, creating questions about jurisdiction and compliance.

2. Ownership Disputes: Universities, companies, and individual researchers may disagree about ownership, authorship, licensing, or confidentiality.

3. Insider Threats: Authorized employees may misuse their access to copy or disclose confidential files.

4. Research Accessibility: Excessively restrictive security measures may interfere with legitimate scientific collaboration.

5. Technological Developments: Cloud computing, AI-assisted biological design, and automated research systems create new challenges involving data leakage and accountability.

6. Enforcement Difficulties: Identifying the person responsible for unauthorized access may be difficult where multiple systems and jurisdictions are involved.

9. SUGGESTIONS FOR LEGAL AND POLICY REFORM

Establish risk-based cybersecurity standards for sensitive biological design repositories.

Clarify responsibilities among research institutions, biotechnology companies, and cloud-service providers.

Encourage encryption, multifactor authentication, secure backups, and access logging.

Establish clear procedures for reporting and investigating biological data breaches.

Promote training in cybersecurity, research ethics, and intellectual property protection.

Develop sector-specific guidance for synthetic biology and genomic databases.

Ensure that security requirements remain proportionate and do not unnecessarily obstruct legitimate research.

Encourage periodic security audits and independent compliance reviews.

10. CONCLUSION

Encryption and security of biological design files are essential for protecting scientific innovation, confidential biotechnology information, personal genomic data, and responsible research.

Effective protection requires encryption, access controls, secure key management, audit trails, contractual safeguards, and legal accountability. In India, the Information Technology Act, 2000, the Digital Personal Data Protection Act, 2023 where applicable, and relevant intellectual property laws provide important elements of the legal framework.

Judicial decisions concerning privacy, confidential information, and unauthorized computer access offer useful principles for interpreting these issues, although the cited cases do not directly establish a universal encryption requirement for biological design files.

In conclusion, the law should ensure that biological design files remain confidential, authentic, and accessible to authorized researchers while being protected against unlawful access, alteration, theft, and misuse. A balanced framework can protect biosecurity and privacy without unnecessarily restricting scientific progress.

FINAL REMARK: Encryption is an important technical safeguard, but effective legal protection also requires lawful data processing, clear access permissions, contractual confidentiality, reliable audit records, and accountability for security breaches.